Who
Terry J. Rosen
Director
Company insider
Files Form 4 as: Director, IDEAYA Biosciences; Chief Executive Officer, Arcus Biosciences.
In numbers
- Trades disclosed
- 81
- Buys
- 22
- Sells
- 9
- Bought
- $3.7M
- Sold
- $2.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 19 Mar 2018
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —79,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —315,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —315,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —79,000 at $0.00 | filing |
| 8 Jan 2026filed 9 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code G | —35,000 at $0.00 | filing |
| 8 Jan 2026filed 9 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code G | —35,000 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code G | —2,400 at $0.00 | filing |
| 30 Dec 2025filed 2 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code G | —2,400 at $0.00 | filing |
| 17 Dec 2025filed 18 Dec 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Sold | $570K25,744 at $22.16 | filing |
| 16 Dec 2025filed 18 Dec 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Sold | $633K28,947 at $21.88 | filing |
| 24 Jun 2025filed 26 Jun 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Feb 2025filed 27 Feb 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Bought | $202K19,800 at $10.18 | filing |
| 23 Jan 2025filed 27 Jan 2025 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —650,000 at $0.00 | filing |
| 23 Jan 2025filed 27 Jan 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 15 Dec 2024filed 17 Dec 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code F | $609K37,882 at $16.08 | filing |
| 15 Jun 2024filed 18 Jun 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code F | $215K12,670 at $16.97 | filing |
| 31 May 2024filed 31 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,200 at $0.00 | filing |
| 23 Jan 2024filed 25 Jan 2024 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —405,900 at $0.00 | filing |
News
Arcus Biosciences Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer DataRCUS · investors.com · 20 Oct 2026Invivyd (NASDAQ:IVVD) and Arcus Biosciences (NYSE:RCUS) Critical ContrastRCUS · themarketsdaily.com · 19 Oct 2026Valion Bio, Inc. Common Stock (NASDAQ:VBIO) vs. Arcus Biosciences (NYSE:RCUS) Head-To-Head ComparisonRCUS · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Terry J. Rosen; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.